Report copyright - Cancer Immunity 1:7 (2001) - ARTICLE(X-axis). Tumor-bearing mice were treated with buffer, Meth A-derived gp96 at 0.5, 1.0 or 5.0 µg/day, or liver-derived gp96 at 0.5 or 1.0 µg/day
Please pass captcha verification before submit form